determin vitro antimicrobi spectrum activ ingredi vehicl final formul use standard cultur recent isol strain speci seri recent isol mesophil strain includ member normal flora cutan pathogen 50 isol speci half must fresh clinic isol select ii determin minim inhibitori concentr mic use methodolog establish nation committe clinic laboratori standard entitl method dilut antimicrobi suscept test bacteria grow aerob document m7a2 2d ed 10 8 1990 incorpor refer accord 5 u c 552 1 cfr part 51 copi avail nation committe clinic laboratori standard 771 east lancast ave villanova pa 19085 may examin center drug evalu research 7520 standish pl suit 201 rockvil md offic feder regist 800 north capitol st nw suit 700 washington dc twenti five fresh clinic isol 25 laboratori strain organ list section includ vitro test must includ american type cultur collect atcc refer strain avail american type cultur collect 12301 parklawn dr rockvil md 20852 specifi paragraph 1 ii 1 ii b section agenc requir organ use test unless data present agenc organ equal repres organ associ nosocomi infect must claim either direct implic product activ organ reduc number organ test follow organ includ note special media environment condit may requir gram neg organ acinetobact speci bacteroid fragili haemophilu influenza enterobact speci escherichia coli atcc no 11229 25922 klebsiella speci includ klebsiella pneumonia pseudomona aeruginosa atcc no 15442 27853 proteu mirabili serratia marcescen atcc 14756 b gram posit organ staphylococci staphylococcu aureu atcc no 6538 29213 coagulas neg staphylococci staphylococcu epidermidi atcc 12228 staphylococcu homini staphylococcu haemolyticu staphylococcu saprophyticu micrococcu luteu atcc 7468 streptococci streptococcu pyogen enterococcu faecali atcc 29212 enterococcu faecium streptococcu pneumonia c yeast candida speci candida albican iii determin possibl develop resist chemic two approach determin emerg resist particular antimicrobi use first approach involv determin evolut point mutat sequenti passag organ increas concentr antimicrobi includ cultur medium second approach thorough survey publish literatur determin whether resist report antimicrobi ingredi survey includ inform microbi contamin market product contain antimicrobi ingredi question irrespect drug concentr survey cover countri product contain activ ingredi market inform submit foreign languag includ translat altern approach determin develop resist submit petit accord 10 30 chapter petit contain suffici data show altern approach provid reliabl indic develop resist particular antimicrobi ingredi iv time kill studi assess vitro spectrum antimicrobi provid inform type genera speci may consid suscept condit test procedur describ paragraph 1 ii section howev inform also requir allow assess rapidli antimicrobi product produc effect inform may deriv vitro time kill curv studi use select batteri organ specifi drug concentr